Suchergebnisse - "Nakamura, Toshitaka"

PubPharm (531)

1

Assessing the activity of benzodioxol, phenol and aniline derivatives as radical trapping antioxidants that inhibit ferroptosis

enthalten in: chemRxiv.org | 2024

von Schricker, H. | Mouzayek, M. | Wanninger, J. | +8

2

A tangible method to assess native ferroptosis suppressor activity

enthalten in: Cell reports methods | 2024

von Nakamura, T. | Ito, J. | Mourão, A. | +4

3

Inhibition of 7-dehydrocholesterol reductase prevents hepatic ferroptosis under an active state of sterol synthesis

enthalten in: Nature communications | 2024

von Yamada, N. | Karasawa, T. | Ito, J. | +17

4

Integrated chemical and genetic screens unveil FSP1 mechanisms of ferroptosis regulation

enthalten in: Nature structural & molecular biology | 2023

von Nakamura, T. | Mishima, E. | Yamada, N. | +11

5

Reliability of early stage symptoms/clinical findings of osteonecrosis of the jaw : Japanese Osteoporosis Intervention Trial-05 (JOINT-05)

enthalten in: Journal of bone and mineral metabolism | 2023

von Taguchi, A. | Tanaka, S. | Ozaki, T. | +9

6

Tissue Acceleration as a Novel Metric for Surgical Performance During Carotid Endarterectomy

enthalten in: Operative neurosurgery (Hagerstown, Md.) | 2023

von Sugiyama, T. | Ito, M. | Sugimori, H. | +8

7

Phase separation of FSP1 promotes ferroptosis

enthalten in: Nature | 2023

von Nakamura, T. | Hipp, C. | Santos Dias Mourão, A. | +10

CommentIn: Nat Rev Cancer. 2023 Sep;23(9):578. - PMID 37491632

8

DHODH inhibitors sensitize to ferroptosis by FSP1 inhibition

enthalten in: Nature | 2023

von Mishima, E. | Nakamura, T. | Zheng, J. | +4

CommentOn: Nature. 2021 May;593(7860):586-590. - PMID 33981038

9

Postoperative Adjuvant Anastrozole for 10 or 5 Years in Patients With Hormone Receptor-Positive Breast Cancer : AERAS, a Randomized Multicenter Open-Label Phase III Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2023

von Iwase, T. | Saji, S. | Iijima, K. | +15

ErratumIn: J Clin Oncol. 2023 Aug 10;41(23):3962. - PMID 37364217

10

Effect of Bone Resorption Inhibitors on Serum Cholesterol Level and Fracture Risk in Osteoporosis : Randomized Comparative Study Between Minodronic Acid and Raloxifene

enthalten in: Calcified tissue international | 2023

von Ohta, H. | Uemura, Y. | Sone, T. | +9

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[54]